India To Reach $5-Trillion Goal 'Sooner Than We Think': Kiran Mazumdar-Shaw
India will reach its goal of a $5-trillion economy "a taint sooner than we think", Biocon Executive Chairperson Kiran Mazumdar-Shaw has said.
Biotech will also have a huge role in contributing to the $5-trillion goal, according to Mazumdar-Shaw, who is also the chairperson of the Vision Group for Biotechnology of the Karnataka government.
"India is on a roll," she told BQ Prime on the sidelines of the Bengaluru Tech Summit 2023. "We have an impressive digital urban infrastructure which we're leveraging—from payment gateways to direct transfers—and many other aspects of the economy, including healthcare."
It was earlier forecasted that the biotech economy would be at $150 billion by end of 2025, but it is already tracking at $137 billion, according to Mazumdar-Shaw.
"Attaining this target within the fiscal is very doable, which means we'll have to revise our targets for 2025 closer to $200 billion and beyond. I'm excited with the leaps and bounds being made in biotech. Health data is also proving to be a large opportunity," she said.
The Karnataka government also unveiled a fresh draft biotech policy for the state. "We keep revising our biotech policies regularly. This is yet another revision, given the fact that these are emerging technologies. So, this draft biotech policy factors the new technologies like digital biotechnology, use of data (and) AI to drive drug discovery and manufacturing," Mazumdar-Shaw said.
She pointed out that the state is also looking at newer areas like synthetic biology which also uses new technologies to accelerate the pace of development.
"We're looking at cell and gene therapies, and regulatory sandboxes we can create to further augment the startup ecosystem and accelerate the lab to market access of new technologies."
#BengaluruTechSummit | #Biocon's Executive Chairperson, Kiran Mazumdar-Shaw(@kiranshaw), talks about how #biotechnology has a major role to play in India becoming a $5 trillion economy. @Bioconlimited @Rish_Bhat
November 30, 2023
For the latest news and updates, visit https://t.co/gXeGqKPzih pic.twitter.com/PQtwmTTgIY
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
